Vaxxinity Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Vaxxinity current Real Value cannot be determined due to lack of data. The regular price of Vaxxinity is $0.0. Our model measures the value of Vaxxinity from inspecting the company fundamentals such as Return On Equity of -1.51, shares owned by institutions of 12.24 %, and Shares Outstanding of 112.91 M as well as reviewing its technical indicators and probability of bankruptcy.
Vaxxinity Total Value Analysis
Vaxxinity is at this time anticipated to have valuation of (1.39 M) with market capitalization of 14.09 M, debt of 15.17 M, and cash on hands of 128.23 M. The negative valuation of Vaxxinity may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Vaxxinity fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(1.39 M) | 14.09 M | 15.17 M | 128.23 M |
Vaxxinity Asset Utilization
One of the ways to look at asset utilization of Vaxxinity is to check how much profit was generated for every dollar of assets it reports. Vaxxinity has a negative utilization of assets of -0.48 %, losing $0.004834 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Vaxxinity shows how discouraging it operates for each dollar spent on its assets.Vaxxinity Ownership Allocation
Vaxxinity shows a total of 112.91 Million outstanding shares. Vaxxinity maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. On January 19, 2024, Senator Rick Scott of US Senate acquired under $15k worth of Vaxxinity's common stock.Vaxxinity Profitability Analysis
Net Loss for the year was (56.93 M) with loss before overhead, payroll, taxes, and interest of (1.87 M).Vaxxinity Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 126.5 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Vaxxinity Pink Sheet
If you are still planning to invest in Vaxxinity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaxxinity's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |